Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States.
Revenue (Most Recent Fiscal Year) | $6.78B |
Net Income (Most Recent Fiscal Year) | $711.50M |
PE Ratio (Current Year Earnings Estimate) | 12.65 |
PE Ratio (Trailing 12 Months) | 12.91 |
PEG Ratio (Long Term Growth Estimate) | 1.30 |
Price to Sales Ratio (Trailing 12 Months) | 1.33 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.46 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 8.11 |
Pre-Tax Margin (Trailing 12 Months) | 12.85% |
Net Margin (Trailing 12 Months) | 10.70% |
Return on Equity (Trailing 12 Months) | 11.93% |
Return on Assets (Trailing 12 Months) | 5.50% |
Current Ratio (Most Recent Fiscal Quarter) | 1.12 |
Quick Ratio (Most Recent Fiscal Quarter) | 0.75 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.54 |
Inventory Turnover (Trailing 12 Months) | 5.81 |
Book Value per Share (Most Recent Fiscal Quarter) | $8.95 |
Earnings per Share (Most Recent Fiscal Quarter) | $0.23 |
Earnings per Share (Most Recent Fiscal Year) | $0.99 |
Diluted Earnings per Share (Trailing 12 Months) | $1.04 |
Exchange | NYSE |
Sector | Basic Materials |
Industry | Specialty Chemicals |
Common Shares Outstanding | 681.43M |
Free Float | 673.25M |
Market Capitalization | $8.89B |
Average Volume (Last 20 Days) | 11.60M |
Beta (Past 60 Months) | 1.09 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 1.20% |
Percentage Held By Institutions (Latest 13F Reports) | 95.08% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |